Development and Validation of a New HPLC Method for Quantification of a Novel Antifungal Drug Based on 1,3,4-Thiadiazole and its Impurities

Chromatographic behavior of a new antifungal drug, (2-[(Z)-1-(3,5-diphenyl-1,3,4-thiadiazol-2(3H)-ylidene)-methyl]-3,5-diphenyl-1,3,4-thiadiazol-3-ium chloride (TDZ), and its impurities was studied using several types of columns, mobile phases and elution modes. A new reversed phase high-performance...

Full description

Saved in:
Bibliographic Details
Published inChromatographia Vol. 82; no. 11; pp. 1633 - 1639
Main Authors Sipkina, N. Yu, Polyakova, M. V., Yakovlev, I. P.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.11.2019
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Chromatographic behavior of a new antifungal drug, (2-[(Z)-1-(3,5-diphenyl-1,3,4-thiadiazol-2(3H)-ylidene)-methyl]-3,5-diphenyl-1,3,4-thiadiazol-3-ium chloride (TDZ), and its impurities was studied using several types of columns, mobile phases and elution modes. A new reversed phase high-performance liquid chromatography (HPLC) method for the determination of TDZ and its impurities in a pharmaceutical substance and dosage form (tablets, 60 mg) was developed and validated. The optimal chromatographic separation of TDZ and its impurities was performed on a 5-μm C8 column (4.6 mm × 250 mm, I.D.). The mobile phase consisted of 0.03% TFA in water (pH 2.5) and acetonitrile under gradient elution condition (from 40:80 v/v to 80:20 v/v for 20 min) at a flow rate of 1.0 mL min −1 . UV detection was set at a wavelength of 250 nm. The limit of detection (LOD) and quantification (LOQ) were 0.05 and 0.1 μg mL −1 , respectively. The method showed good linearity ( r 2  > 0.999) over the assayed concentration range (0.1–1.4 μg mL −1 for quantification of impurities and 0.005–0.013 mg mL −1 for quantification TDZ) and demonstrated good intra- and inter-day precision and accuracy. The method was validated and successfully applied for quantitative determination of TDZ and its impurities in both the pharmaceutical substance and tablets.
AbstractList Chromatographic behavior of a new antifungal drug, (2-[(Z)-1-(3,5-diphenyl-1,3,4-thiadiazol-2(3H)-ylidene)-methyl]-3,5-diphenyl-1,3,4-thiadiazol-3-ium chloride (TDZ), and its impurities was studied using several types of columns, mobile phases and elution modes. A new reversed phase high-performance liquid chromatography (HPLC) method for the determination of TDZ and its impurities in a pharmaceutical substance and dosage form (tablets, 60 mg) was developed and validated. The optimal chromatographic separation of TDZ and its impurities was performed on a 5-μm C8 column (4.6 mm × 250 mm, I.D.). The mobile phase consisted of 0.03% TFA in water (pH 2.5) and acetonitrile under gradient elution condition (from 40:80 v/v to 80:20 v/v for 20 min) at a flow rate of 1.0 mL min −1 . UV detection was set at a wavelength of 250 nm. The limit of detection (LOD) and quantification (LOQ) were 0.05 and 0.1 μg mL −1 , respectively. The method showed good linearity ( r 2  > 0.999) over the assayed concentration range (0.1–1.4 μg mL −1 for quantification of impurities and 0.005–0.013 mg mL −1 for quantification TDZ) and demonstrated good intra- and inter-day precision and accuracy. The method was validated and successfully applied for quantitative determination of TDZ and its impurities in both the pharmaceutical substance and tablets.
Chromatographic behavior of a new antifungal drug, (2-[(Z)-1-(3,5-diphenyl-1,3,4-thiadiazol-2(3H)-ylidene)-methyl]-3,5-diphenyl-1,3,4-thiadiazol-3-ium chloride (TDZ), and its impurities was studied using several types of columns, mobile phases and elution modes. A new reversed phase high-performance liquid chromatography (HPLC) method for the determination of TDZ and its impurities in a pharmaceutical substance and dosage form (tablets, 60 mg) was developed and validated. The optimal chromatographic separation of TDZ and its impurities was performed on a 5-μm C8 column (4.6 mm × 250 mm, I.D.). The mobile phase consisted of 0.03% TFA in water (pH 2.5) and acetonitrile under gradient elution condition (from 40:80 v/v to 80:20 v/v for 20 min) at a flow rate of 1.0 mL min−1. UV detection was set at a wavelength of 250 nm. The limit of detection (LOD) and quantification (LOQ) were 0.05 and 0.1 μg mL−1, respectively. The method showed good linearity (r2 > 0.999) over the assayed concentration range (0.1–1.4 μg mL−1 for quantification of impurities and 0.005–0.013 mg mL−1 for quantification TDZ) and demonstrated good intra- and inter-day precision and accuracy. The method was validated and successfully applied for quantitative determination of TDZ and its impurities in both the pharmaceutical substance and tablets.
Author Sipkina, N. Yu
Yakovlev, I. P.
Polyakova, M. V.
Author_xml – sequence: 1
  givenname: N. Yu
  orcidid: 0000-0001-7501-8254
  surname: Sipkina
  fullname: Sipkina, N. Yu
  email: nadya.sipkina@pharminnotech.com
  organization: St. Petersburg State Chemical Pharmaceutical University
– sequence: 2
  givenname: M. V.
  surname: Polyakova
  fullname: Polyakova, M. V.
  organization: St. Petersburg State Chemical Pharmaceutical University
– sequence: 3
  givenname: I. P.
  surname: Yakovlev
  fullname: Yakovlev, I. P.
  organization: St. Petersburg State Chemical Pharmaceutical University
BookMark eNp9kMtOWzEQhi0EEiH0BVhZYovp2D4XnyUNpUFKgUq0W8v4EoxO7GCf06Z9hb50HYJEV6xGM_r-f6TvCO2HGCxCJxTOKUD7MVPgvCVAOwK87Sqy2UMT2lBGKKVsH00AoCO16PghOsr5qaysa5oJ-ntpf9o-rlc2DFgFg3-o3hs1-BhwdFjhG_sLz-8WM_zVDo_RYBcT_jaqMHjn9f9cLD34Ynsfw1L1-DKNS_xJZWtwYegZP6vI_aNXxqs_sbcvz_yQ8fVqPSY_eJuP0YFTfbYfXucUfb_6fD-bk8Xtl-vZxYJoTruBCN0440RdGw21aoyoARpmW6tFoxQ3VdeCEqzTD2ArwRmtHYADXWvNGNWaT9Hprned4vNo8yCf4phCeSkZh1pUoigtFNtROsWck3VynfxKpd-SgtxKlzvpskiXL9LlpoT4LpQLHJY2vVW_k_oHGNyG0w
CitedBy_id crossref_primary_10_1016_j_molstruc_2023_136439
crossref_primary_10_3390_molecules26061708
crossref_primary_10_1016_j_cdc_2023_101047
crossref_primary_10_1016_j_plaphy_2023_107843
crossref_primary_10_1016_j_molstruc_2023_135619
crossref_primary_10_1055_a_1625_3121
crossref_primary_10_1080_10408347_2022_2032587
Cites_doi 10.1007/s11094-017-1630-3
10.3389/fphar.2014.00202
10.1016/j.ejmech.2004.06.007
10.1021/cr400131u
10.1002/cmdc.201200355
10.1111/cbdd.12125
10.2174/1389557515666150519104057
10.3389/fmicb.2017.00036
10.1016/j.ijantimicag.2007.07.019
10.1039/P19750001386
10.3390/molecules22111926
10.1016/j.ejmech.2010.07.023
ContentType Journal Article
Copyright Springer-Verlag GmbH Germany, part of Springer Nature 2019
Copyright Springer Nature B.V. 2019
Copyright_xml – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2019
– notice: Copyright Springer Nature B.V. 2019
DBID AAYXX
CITATION
DOI 10.1007/s10337-019-03794-x
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1612-1112
EndPage 1639
ExternalDocumentID 10_1007_s10337_019_03794_x
GrantInformation_xml – fundername: Ministry of Education of the Russian Federation
  grantid: 115080740020
GroupedDBID ---
--K
-4Y
-58
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
06C
06D
0R~
0VY
199
1B1
1N0
1SB
2.D
203
28-
29B
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3SX
4.4
406
408
40D
40E
53G
5GY
5QI
5VS
6NX
78A
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAGAY
AAGCJ
AAHNG
AAIAL
AAIKT
AAJKR
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUCO
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABDZT
ABECU
ABEFU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACTTH
ACVWB
ACWMK
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFDYV
AFEXP
AFFNX
AFGCZ
AFLOW
AFNRJ
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJGSW
AJRNO
AJZVZ
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AYJHY
AZFZN
B-.
BA0
BBWZM
BDATZ
BGNMA
CAG
COF
CS3
CSCUP
D0L
DDRTE
DL5
DNIVK
DPUIP
DU5
EBLON
EBS
EIOEI
EJD
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
HF~
HG5
HG6
HMJXF
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IXE
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KDC
KOV
KOW
LLZTM
M41
M4Y
MA-
MQGED
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
P19
P2P
P9N
PF0
PT4
PT5
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
RNS
ROL
RPX
RPZ
RSV
RZK
S16
S1Z
S26
S27
S28
S3B
SAP
SCG
SCLPG
SCM
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SQXTU
SRMVM
SSLCW
STPWE
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
UG4
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
W4F
WH7
WJK
WK6
WK8
XPP
Y6R
YLTOR
Z45
Z5O
Z7R
Z7S
Z7U
Z7V
Z7W
Z7X
Z7Y
Z7Z
Z83
Z85
Z86
Z87
Z88
Z8M
Z8N
Z8O
Z8P
Z8Q
Z8R
Z8S
Z8T
Z8W
Z91
ZE2
ZMTXR
~02
~KM
AACDK
AAEOY
AAHBH
AAJBT
AASML
AAYXX
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGJZZ
AGQEE
AGRTI
AIGIU
CITATION
H13
ID FETCH-LOGICAL-c319t-8c6fdf855dc05a6d850062e7ec86aa3d4970a829cb0e483215f00f0c5cc221cc3
IEDL.DBID AGYKE
ISSN 0009-5893
IngestDate Thu Oct 10 18:52:15 EDT 2024
Thu Sep 12 17:22:44 EDT 2024
Sat Dec 16 12:04:18 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Validation
Drug
1,3,4-Thiadiazole
Antifungal
HPLC
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c319t-8c6fdf855dc05a6d850062e7ec86aa3d4970a829cb0e483215f00f0c5cc221cc3
ORCID 0000-0001-7501-8254
PQID 2305848007
PQPubID 2043669
PageCount 7
ParticipantIDs proquest_journals_2305848007
crossref_primary_10_1007_s10337_019_03794_x
springer_journals_10_1007_s10337_019_03794_x
PublicationCentury 2000
PublicationDate 2019-11-01
PublicationDateYYYYMMDD 2019-11-01
PublicationDate_xml – month: 11
  year: 2019
  text: 2019-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Heidelberg
PublicationSubtitle An International Journal for Separation Science
PublicationTitle Chromatographia
PublicationTitleAbbrev Chromatographia
PublicationYear 2019
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References CallaghanPDGibsonMSElliottAJSynthesis of 1H-4,1,2-benzothiadiazines from substituted N-acetyl-N-aryl-N′-thioaroylhydrazinesJ Chem Soc Perkin Trans19751141386139010.1039/P19750001386
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) (2005). ICH harmonised tripartite guideline. Validation of analytical procedures: text and methodology. Q2(R1), November 2005
FordCBFuntJMAbbeyDIssiLGuiducciCMartinezDADeloreyTLiBYWhiteTCCuomoCRaoRPBermanJThompsonDARegevAThe evolution of drug resistance in clinical isolates of Candida albicansElife20153127
ShaoPLHuangaLMHsuehPRRecent advances and challenges in the treatment of invasive fungal infectionsInt J Antimicrob Agents2007304874951:CAS:528:DC%2BD2sXht12isbnL10.1016/j.ijantimicag.2007.07.01917961990
Scorzoni L, de Paula e Silva ACA, Marcos CM, Assato PA, de Melo WCMA, de Oliveira HC, Costa-Orlandi CB, Mendes-Giannini MJS, Fusco-Almeida AM (2017) Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol 08:36
KumarDKumarMNChangKHShahKSynthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazolesEur J Med Chem201045466446681:CAS:528:DC%2BC3cXhtV2iur%2FF10.1016/j.ejmech.2010.07.02320692741
JainAKSharmaSVaidyaARavichandranVAgrawalRK1,3,4-Thiadiazole and its derivatives: a review on recent progress in biological activitiesChem Biol Drug Des20138155575761:CAS:528:DC%2BC3sXmvFSnsrw%3D10.1111/cbdd.1212523452185
HuYLiCYWangXMYangYHZhuHL1,3,4-Thiadiazole: synthesis, reactions, and applications in medicinalAgric Mater Chem Chem Rev201411410557256101:CAS:528:DC%2BC2cXlvFOmsLY%3D10.1021/cr400131u
KoshevenkoASYakovlevIPYuskovetsVNAnan’evaEPKuz’michNNKsenofontovaGVSynthesis and antifungal activity of new 2-[(Z)-1-(3,5-diaryl-1,3,4-thiadiazol-2(3H)-ylidene)methyl]-3,5-diaryl-1,3,4-ium chloridesPharm Chem J20175164444471:CAS:528:DC%2BC2sXhs1Cnsr3N10.1007/s11094-017-1630-3
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) (2006). ICH harmonised tripartite guideline. Impurities in new drug substances. Q3A(R2), 25 October 2006
MatysiakJBiological and pharmacological activities of 1,3,4-thiadiazole based compoundsMini Rev Med Chem20151597627751:CAS:528:DC%2BC2MXpsVWnsrs%3D10.2174/138955751566615051910405725985954
PrasadRRawalMKEfflux pump proteins in antifungal resistanceFront Pharmacol2014520210.3389/fphar.2014.002021:CAS:528:DC%2BC2MXhtlSjsrrM252215154148622
International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH) (2006). ICH harmonised tripartite guideline. Impurities in new drug products. Q3B(R2), 2 June 2006
LiYGengJLiuYYuSZhaoGThiadiazole—a promising structure in medicinal chemistryChem Med Chem201281274110.1002/cmdc.2012003551:CAS:528:DC%2BC38XhslKqtLnF23208773
SzafrańskiKSławińskiJKędziaAKwapiszESyntheses of novel 4-substituted N-(5-amino-1H-1,2,4-triazol-3-yl)pyridine-3-sulfonamide derivatives with potential antifungal activityMolecules20172211192610.3390/molecules221119261:CAS:528:DC%2BC1cXisVGjt7g%3D6150321
DemirbasNKaraogluSASancakKSynthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]-thiadiazole-2-yl)methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo- [1,2,4]triazole-3-yl)methyl-5-oxo-[1,2,4]triazole derivativesEur J Med Chem2004397938041:CAS:528:DC%2BD2cXntVOhuro%3D10.1016/j.ejmech.2004.06.00715337292
J Matysiak (3794_CR7) 2015; 15
CB Ford (3794_CR5) 2015; 3
AS Koshevenko (3794_CR12) 2017; 51
Y Hu (3794_CR6) 2014; 114
PD Callaghan (3794_CR13) 1975; 1
3794_CR16
Y Li (3794_CR8) 2012; 8
K Szafrański (3794_CR4) 2017; 22
R Prasad (3794_CR3) 2014; 5
3794_CR14
D Kumar (3794_CR9) 2010; 45
3794_CR15
N Demirbas (3794_CR10) 2004; 39
AK Jain (3794_CR11) 2013; 81
PL Shao (3794_CR2) 2007; 30
3794_CR1
References_xml – volume: 51
  start-page: 444
  issue: 6
  year: 2017
  ident: 3794_CR12
  publication-title: Pharm Chem J
  doi: 10.1007/s11094-017-1630-3
  contributor:
    fullname: AS Koshevenko
– volume: 5
  start-page: 202
  year: 2014
  ident: 3794_CR3
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2014.00202
  contributor:
    fullname: R Prasad
– volume: 39
  start-page: 793
  year: 2004
  ident: 3794_CR10
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2004.06.007
  contributor:
    fullname: N Demirbas
– volume: 114
  start-page: 5572
  issue: 10
  year: 2014
  ident: 3794_CR6
  publication-title: Agric Mater Chem Chem Rev
  doi: 10.1021/cr400131u
  contributor:
    fullname: Y Hu
– volume: 8
  start-page: 27
  issue: 1
  year: 2012
  ident: 3794_CR8
  publication-title: Chem Med Chem
  doi: 10.1002/cmdc.201200355
  contributor:
    fullname: Y Li
– volume: 81
  start-page: 557
  issue: 5
  year: 2013
  ident: 3794_CR11
  publication-title: Chem Biol Drug Des
  doi: 10.1111/cbdd.12125
  contributor:
    fullname: AK Jain
– volume: 3
  start-page: 1
  year: 2015
  ident: 3794_CR5
  publication-title: Elife
  contributor:
    fullname: CB Ford
– volume: 15
  start-page: 762
  issue: 9
  year: 2015
  ident: 3794_CR7
  publication-title: Mini Rev Med Chem
  doi: 10.2174/1389557515666150519104057
  contributor:
    fullname: J Matysiak
– ident: 3794_CR1
  doi: 10.3389/fmicb.2017.00036
– volume: 30
  start-page: 487
  year: 2007
  ident: 3794_CR2
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2007.07.019
  contributor:
    fullname: PL Shao
– ident: 3794_CR14
– ident: 3794_CR15
– ident: 3794_CR16
– volume: 1
  start-page: 1386
  issue: 14
  year: 1975
  ident: 3794_CR13
  publication-title: J Chem Soc Perkin Trans
  doi: 10.1039/P19750001386
  contributor:
    fullname: PD Callaghan
– volume: 22
  start-page: 1926
  issue: 11
  year: 2017
  ident: 3794_CR4
  publication-title: Molecules
  doi: 10.3390/molecules22111926
  contributor:
    fullname: K Szafrański
– volume: 45
  start-page: 4664
  year: 2010
  ident: 3794_CR9
  publication-title: Eur J Med Chem
  doi: 10.1016/j.ejmech.2010.07.023
  contributor:
    fullname: D Kumar
SSID ssj0002966
Score 2.3248978
Snippet Chromatographic behavior of a new antifungal drug, (2-[(Z)-1-(3,5-diphenyl-1,3,4-thiadiazol-2(3H)-ylidene)-methyl]-3,5-diphenyl-1,3,4-thiadiazol-3-ium chloride...
SourceID proquest
crossref
springer
SourceType Aggregation Database
Publisher
StartPage 1633
SubjectTerms Acetonitrile
Analytical Chemistry
Chemistry
Chemistry and Materials Science
Chromatography
Elution
Flow velocity
Fungicides
High performance liquid chromatography
Impurities
Ions
Laboratory Medicine
Linearity
Original
Pharmaceuticals
Pharmacy
Proteomics
Tablets
Thiadiazoles
Title Development and Validation of a New HPLC Method for Quantification of a Novel Antifungal Drug Based on 1,3,4-Thiadiazole and its Impurities
URI https://link.springer.com/article/10.1007/s10337-019-03794-x
https://www.proquest.com/docview/2305848007
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB1BOcCFHVE2-cCNGqVxncbHUpayCqQWwSly7BgQ0KI2lRC_wE8zdhJatgPXxLIVz3jmObM8gG0ZGxUbqSgaSLygSKOpZNpQZrhAd6IRFLgs34ug1amd3PCbUR23S3YvIpLOUI_VujFmsyQF9RgqEUXgOMUtLXUJphpHt6cHnwbYF1mI0v735-iP81qZ32f56o9GIPNbXNS5m8M5aBdFO1mWyePuMI131dvPHo7_-ZJ5mM3hJ2lk-rIAE0l3EaabBevbEryPZRER2dXkGoF6xrtEeoZIglaRtC7PmuTccU8TBL3kaiiznKPxcT2chzTsc7QnuOZ-f3hH9tBpaoJjqhVWqdH2_YPtjfDWe0rcYg_pgBw_v1hGPbzBL0Pn8KDdbNGcsIEqPMkpDVVgtAk518rjMtAhtyWaST1RYSBRBWqi7snQFyr2kpqlSOLG84ynuFK-X1WKrUCp2-smq0DQULCgqkXMfe2asAnpMxOIxPYy9kRYhp1CbNFL1pcjGnVgthsc4QZHboOj1zJsFJKN8jM6iPDyhegLAXO9DJVCUqPXf8-29r_h6zDjW2G7AsYNKKX9YbKJSCaNt3LN3YLJjt_4ANDA6f8
link.rule.ids 315,786,790,27957,27958,41116,41558,42185,42627,52146,52269
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bT8IwFG4MPuCL8RpR1D74Jk3Guo71EVEyFIgmYHhbunZVEmWES2L8C_5pT7tN0OiDr1vTJvvO5TvruSB0IWItYy0kAQMJAYrQigiqNKGacXAnCkiBzfLt--HQux2xUV4UNi-y3YsrSWup14rdKDVpkpw4FKSIAHPcNP3UTcg1dJtf9tfl2Q2l-e3PwB3npTK_7_HdHa045o9rUett2jtoO6eJuJnhuos2kskeKreK6Wz76GMt2weLicKPQKiz-Ug41VhgsF44vO-2cM_OiMZATvHDUmS5QevrUtgHN81z0Hs483q2fMJX4NwUhjX1Gq15ZPA8Nj0M3tOXxB42Xsxx53VqJt9BpH2Ahu2bQSsk-WAFIkHjFiSQvlY6YExJhwlfBcyUUiaNRAa-AKg83nBE4HIZO4lnRhkx7TjakUxK161LSQ9RaZJOkiOEQaGpX1c8Zq6yzdK4cKn2eWJ6Djs8qKDL4vtG06x_RrTqlGzQiACNyKIRvVVQtYAgynVpHkGQBCwJiG2jgmoFLKvXf-92_L_l56gcDnrdqNvp352gLddIiS06rKLSYrZMToF9LOIzK2yfFJzPqw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NT8IwFG-MJurF-BlR1B68ScNY6ViPCBJQJJiA4bZ07aokuhEYifFf8J_2tWOCRg9e1-Y12a997_fyvhC6FKGWoRaSgIIEB0VoRQRVmlDNOJgTBaTAZvn2vPawejtio5Uqfpvtnocks5oG06UpTssTpcsrhW-UmpRJThwKN4oAi9wwptEkdQ3d-pcudnkWrTQhAAameVE287uM76ZpyTd_hEit5Wntop0FZcT1DOM9tBbF-2irkU9qO0AfK5k_WMQKPwK5zmYl4URjgUGT4Xa_28D3dl40BqKKH-YiyxNa3ZeAHFw330EHwJnN6fwJX4OhUxj2VEq0VCWD57HpZ_CevET2sHE6w53XiZmCB173IRq2bgaNNlkMWSASXl9KfOlppX3GlHSY8JTPTFllVIuk7wmArcprjvBdLkMnqpqxRkw7jnYkk9J1K1LSI7QeJ3F0jDA8bupVFA-Zq2zjNC5cqj0emf7DDvcL6Cr_v8Ek66URLLsmGzQCQCOwaARvBVTMIQgW72oWgMMEjAlIbq2ASjksy-W_pZ38b_sF2uw3W0G307s7RduuuSS2_rCI1tPpPDoDIpKG5_aufQJkltPw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+Validation+of+a+New+HPLC+Method+for+Quantification+of+a+Novel+Antifungal+Drug+Based+on+1%2C3%2C4-Thiadiazole+and+its+Impurities&rft.jtitle=Chromatographia&rft.au=Sipkina%2C+N.+Yu&rft.au=Polyakova%2C+M.+V.&rft.au=Yakovlev%2C+I.+P.&rft.date=2019-11-01&rft.issn=0009-5893&rft.eissn=1612-1112&rft.volume=82&rft.issue=11&rft.spage=1633&rft.epage=1639&rft_id=info:doi/10.1007%2Fs10337-019-03794-x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10337_019_03794_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-5893&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-5893&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-5893&client=summon